Frontiers in Anti-Infective Drug Discovery
Released: Sep 12, 2017
Publisher: Bentham Science Publishers
Format: Paperback, 211 pages
Related ISBN: 9781608058617
Description:
This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field. The fifth volume of this series features 6 chapters that cover the following topics: - Virus infection pathways in living cells - Antimicrobial activity of natural products (essential oils and food products) - Medicinal plants that produce immunomodulators of veterinary interest - In silico approaches for determination of drug targets
Best prices to buy, sell, or rent ISBN 9781681082929
Frequently Asked Questions about Frontiers in Anti-Infective Drug Discovery
You can buy the Frontiers in Anti-Infective Drug Discovery book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $98.99 on Amazon and is available from 1 sellers at the moment.
If you’re interested in selling back the Frontiers in Anti-Infective Drug Discovery book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Frontiers in Anti-Infective Drug Discovery book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.